Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Olivia Evans
Observed name:
O.R. Evans
Institutions:
Queen Mary University of London,
Barts Health NHS Trust,
Royal London Hospital,
Cancer Research UK
Observed institutions:
St Bartholomew's Hospital,
Queen Mary University of London,
Barts Health NHS Trust,
Royal London Hospital,
Cancer Research UK,
The Northern Ireland Cancer Centre
show all 6
ORCID:
0000-0002-8012-4964
Observed ORCID:
0000-0002-8012-4964
OpenAlex ID:
A5102883010
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
2020
·
Ranjit Manchanda
, Li Sun
, et al.
·
Cancers
·
85
PDF
Implementation of Multigene Germline and Parallel Somatic Genetic Testing in Epithelial Ovarian Cancer: SIGNPOST Study
2021
·
Dhivya Chandrasekaran
, Monika Sobocan
, et al.
·
Cancers
·
64
PDF
Population-based genetic testing for Women's cancer prevention
2020
·
Olivia Evans
, Faiza Gaba
, et al.
·
Best Practice & Research Clinical Obstetrics & Gynaecology
·
51
Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
2021
·
Faiza Gaba
, Shivam Goyal
, et al.
·
Journal of Medical Genetics
·
40
PDF
Population-based Genetic Testing for Precision Prevention
2020
·
Olivia Evans
, Ranjit Manchanda
·
Cancer Prevention Research
·
40
PDF
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK
2023
·
Samuel Oxley
, Ashwin Kalra
, et al.
·
Cancers
·
6
PDF
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study
2023
·
Monika Sobocan
, Dhivya Chandrasekaran
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
3
2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer
2022
·
Monika Sobocan
, Dhivya Chandrasekaran
, et al.
·
International Journal of Gynecological Cancer
PDF
Adjuvant chemotherapy (AC) use and toxicity in oestrogen receptor positive (ER+), lymph node negative (LN-), Her-2 negative (H2-) breast cancer (<75yrs) in Northern Ireland
2016
·
O.R. Evans
, V. Braden
, et al.
·
Clinical Oncology
Show more works
View as search
Works count:
9
Citation count:
289
H-index:
6
I10-index:
5
Year
Topic
Type